or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    CLLS B Cellectis S.A. 17.90
    ELTX B Elicio Therapeutics, Inc. 1.69
    CRDF B Cardiff Oncology, Inc. 5.91
    LYEL B Lyell Immunopharma, Inc. 3.00
    HOWL C Werewolf Therapeutics, Inc. 1.00
    EBS C Emergent Biosolutions, Inc. 70.98
    HALO C Halozyme Therapeutics, Inc. 1.32
    SNDX C Syndax Pharmaceuticals, Inc. -0.50
    KURA C Kura Oncology, Inc. 1.53
    KYMR C Kymera Therapeutics, Inc. 0.17
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Shell Companies
    Related Stock Lists: Cancer Medicine Clinical Medicine Biopharmaceutical Cancer Immunotherapy Cancer Treatment Lymphoma Peptides Biotechnology Bladder Cancer Blastoma Clinical Development Epidermal Growth Factor Receptor Head And Neck Cancer Hematological Malignancies Melanoma Monoclonal Antibodies Oncology Prostate Cancer Treatment Of A Range Of Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    FBT D First Trust Amex Biotech Index Fund 3.28
    IBB C iShares Nasdaq Biotechnology Index Fund 1.66
    CNCR C Loncar Cancer Immunotherapy ETF 1.32
    WDNA D WisdomTree BioRevolution Fund 1.2
    GDOC C Goldman Sachs Future Health Care Equity ETF 0.74
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare FBT to GDOC Compare FBT to IBB Compare IBB to WDNA

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 2 CRDF Cardiff Oncology GAAP EPS of -$0.22 beats by $0.03, revenue of $0.2M beats by $0.14M
        May 2 KURA Kura Oncology GAAP EPS of -$0.59 misses by $0.03
        May 2 KURA Kura Oncology Reports First Quarter 2024 Financial Results
        May 2 CRDF Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
        May 2 EBS Q1 2024 Emergent BioSolutions Inc Earnings Call
        May 2 EBS Emergent BioSolutions Inc. (NYSE:EBS) Q1 2024 Earnings Call Transcript
        May 2 KYMR Kymera Therapeutics GAAP EPS of -$0.69 beats by $0.04, revenue of $10.3M misses by $2.75M
        May 2 KYMR Kymera Therapeutics Announces First Quarter 2024 Financial Results and Provides a Business Update
        May 2 EBS Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
        May 2 EBS Emergent BioSolutions gains as results top estimates, co to cut 300 jobs
        May 2 EBS Emergent BioSolutions Inc (EBS) (Q1 2024) Earnings Call Transcript Highlights: A Strong Start ...
        May 2 EBS PRESS DIGEST- Wall Street Journal - May 2
        May 2 EBS Emergent BioSolutions (EBS) Q1 2024 Earnings Call Transcript
        May 2 EBS Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
        May 2 EBS Emergent BioSolutions Inc. 2024 Q1 - Results - Earnings Call Presentation
        May 1 EBS Emergent BioSolutions Reports Surprising Q1 2024 Earnings, Exceeding Revenue and Net Income ...
        May 1 CRDF Cardiff Oncology Q1 2024 Earnings Preview
        May 1 KURA Kura Oncology Q1 2024 Earnings Preview
        May 1 EBS Narcan-Maker Emergent BioSolutions to Cut 300 Jobs, Close Facilities
        May 1 EBS Emergent Biosolutions Non-GAAP EPS of $0.59 beats by $1.45, revenue of $300.4M beats by $75.9M
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Shell Companies
        Related Stock Lists: Cancer Biotechnology Lymphoma Medicine Biopharmaceutical Clinical Medicine Immune System Acute Myeloid Leukemia Biology Cancer Treatment Cell Biology Clinical Development Disease Drugs Emerging Technologies Oncogenes Peptides Treatment Of A Range Of Cancer Treatment Of Cancer Tumor
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags